Results 21 to 30 of about 327,168 (302)

Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons? [PDF]

, 2013
Interleukin (IL)-10 and IL-22 are key members of the IL-10 cytokine family that share characteristic properties such as defined structural features, usage of IL-10R2 as one receptor chain, and activation of signal transducer and activator of ...
Mühl, Heiko
core   +2 more sources

TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver

Frontiers in Immunology, 2023
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus does not only lead to pulmonary infection but can also infect other organs such as the gut, the kidney, or the liver.
Jöran Lücke, Jöran Lücke, Jöran Lücke, Mikolaj Nawrocki, Mikolaj Nawrocki, Mikolaj Nawrocki, Josa Schnell, Josa Schnell, Nicholas Meins, Nicholas Meins, Fabian Heinrich, Fabian Heinrich, Tao Zhang, Tao Zhang, Franziska Bertram, Franziska Bertram, Franziska Bertram, Morsal Sabihi, Morsal Sabihi, Marius Böttcher, Marius Böttcher, Marius Böttcher, Tom Blankenburg, Tom Blankenburg, Marie Pfaff, Sara Notz, Jan Kempski, Jan Kempski, Jan Kempski, Jan Kempski, Matthias Reeh, Stefan Wolter, Oliver Mann, Jakob R. Izbicki, Marc Lütgehetmann, Anna Duprée, Anastasios D. Giannou, Anastasios D. Giannou, Anastasios D. Giannou, Benjamin Ondruschka, Samuel Huber, Samuel Huber, Samuel Huber   +42 more
doaj   +1 more source

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial

Annals of Medicine, 2021
Background There are few effective therapies for coronavirus disease 2019 (COVID-19) upon the outbreak of the pandemic. To compare the effectiveness of a novel genetically engineered recombinant super-compound interferon (rSIFN-co) with traditional ...
Chuan Li, Fengming Luo, Chengwu Liu, Nian Xiong, Zhihua Xu, Wei Zhang, Ming Yang, Ye Wang, Dan Liu, Chao Yu, Jia Zeng, Li Zhang, Duo Li, Yanbin Liu, Mei Feng, Ruoyang Liu, Jiandong Mei, Senyi Deng, Zhen Zeng, Yuanhong He, Haiyan Liu, Zhengyu Shi, Meng Duan, Deying Kang, Jiayu Liao, Weimin Li, Lunxu Liu   +26 more
doaj   +1 more source

Treatment of hairy cell leukemia with recombinant alpha 2 interferon [PDF]

Blood, 1985
Abstract Nine patients with progressive hairy cell leukemia were treated with subcutaneous injections of recombinant alpha 2 interferon (2 to 10 X 10(6) U/m2) three times weekly. Eight patients completed at least eight weeks of treatment and were evaluable; one patient with refractory thrombocytopenia died of an intracerebral hemorrhage ...
M J, Ratain, H M, Golomb, J W, Vardiman, E E, Vokes, R H, Jacobs, K, Daly   +5 more
openaire   +3 more sources

IFNα and IFNγ Impede Marek’s Disease Progression [PDF]

, 2019
Marek’s disease virus (MDV) is an alphaherpesvirus that causes Marek’s disease, a malignant lymphoproliferative disease of domestic chickens. While MDV vaccines protect animals from clinical disease, they do not provide sterilizing immunity and allow ...
Bertzbach, Luca D., Fehler, Frank, Harlin, Olof, Härtle, Sonja, Kaspers, Bernd, Kaufer, Benedikt B., Vychodil, Tereza   +6 more
core   +1 more source

Human plasmacytoid dendritic cells and cutaneous melanoma [PDF]

, 2020
The prognosis of metastatic melanoma (MM) patients has remained poor for a long time. However, the recent introduction of effective target therapies (BRAF and MEK inhibitors for BRAFV600-mutated MM) and immunotherapies (anti-CTLA-4 and anti-PD-1) has ...
Bugatti, Mattia, Consoli, Francesca, Monti, Matilde, Vermi, William, Vescovi, Raffaella   +4 more
core   +2 more sources

CLINICAL AND IMMUNOLOGICAL EFFICIENCY OF INTERFERON ALPHA_2 AS A PART OF COMPLEX THERAPY OF CHILDREN, SUFFERING FROM THE LINGERING RECURRENT FORMS OF PSEUDOTUBERCULOSIS

Педиатрическая фармакология, 2007
The researchers have examined 45 children aged between 3 and 14, suffering from the lingering recurrent forms of pseudotuberculosis. 25 children (55,6%) received some conventional therapy, whereas 20 patients (44,3%) used interferon alpha_2. The practice
V.N. Timchenko, N.M. Kalinina, I.V. Babachenko, E.B. Pavlova, T.K. Strebunova, E.V. Barakina   +5 more
doaj   +2 more sources

Tratamento de hemangioma gigante com interferon alfa: relato de dois casos Treatment of giant hemangioma with interferon-alpha: report of two cases

Revista Brasileira de Hematologia e Hemoterapia, 2007
O objetivo do trabalho é descrever o uso de interferon alfa no tratamento de pacientes com hemangioma gigante. Os autores relatam e analisam dois casos de hemangioma gigante em tratamento com interferon alfa. IBS, 3 anos, em acompanhamento no Ambulatório
Ana Julia Balau, Livia C. De Nadai, Mônica S. Bressan, Josiane L. Simão   +3 more
doaj   +1 more source

Human interferon-alpha A, -alpha 2, and -alpha 2(Arg) genes in genomic DNA

Journal of Biological Chemistry, 1993
The frequency in human genomic DNA of three human interferon (IFN) alpha genes which differ from each other by a single base substitution was examined in 11 normal individuals. The polymerase chain reaction (PCR) was used to amplify the coding sequence for the Hu-IFN-alpha 2, Hu-IFN-alpha A, and Hu-IFN-alpha 2(Arg) sequences from genomic DNA.
S L, Emanuel, S, Pestka
openaire   +2 more sources

Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor [PDF]

, 1994
We have shown previously that the antiviral function of CD4+ T lymphocytes against murine cytomegalovirus (MCMV) is associated with the release of interferon- (IFN-).
Hengel, Hartmut, Jonjic, Stipan, Koszinowski, Ulrich H., Lucin, Pero, Messerle, Martin, Polic, Bojan   +5 more
core   +3 more sources